A double-blind comparison of trifluperidol and trifluoperazine in acute schizophrenic patients. 1969

B C Schiele, and J Janecek, and R Zimmermann

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008950 MMPI A personality inventory consisting of statements to be asserted or denied by the individual. The patterns of response are characteristic of certain personality attributes. Minnesota Multiphasic Personality Inventory
D010880 Piperidines A family of hexahydropyridines.
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002090 Butyrophenones Compounds containing phenyl-1-butanone.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant

Related Publications

B C Schiele, and J Janecek, and R Zimmermann
January 1965, The Journal of new drugs,
B C Schiele, and J Janecek, and R Zimmermann
January 1976, Journal of clinical pharmacology,
B C Schiele, and J Janecek, and R Zimmermann
September 1974, Current therapeutic research, clinical and experimental,
B C Schiele, and J Janecek, and R Zimmermann
June 1975, Diseases of the nervous system,
B C Schiele, and J Janecek, and R Zimmermann
January 1976, The Journal of international medical research,
B C Schiele, and J Janecek, and R Zimmermann
September 1964, Current therapeutic research, clinical and experimental,
B C Schiele, and J Janecek, and R Zimmermann
October 1968, Current therapeutic research, clinical and experimental,
B C Schiele, and J Janecek, and R Zimmermann
January 1972, Psychosomatics,
B C Schiele, and J Janecek, and R Zimmermann
March 1967, Diseases of the nervous system,
B C Schiele, and J Janecek, and R Zimmermann
January 1973, Current therapeutic research, clinical and experimental,
Copied contents to your clipboard!